TITLE

Capsaicin Patch 8% (Qutenza)

AUTHOR(S)
Elliott, William T.; Chan, James
PUB. DATE
January 2010
SOURCE
Internal Medicine Alert;1/15/2010, Vol. 32 Issue 1, p5
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the clinical implications of capsaicin patch as a drug in treating neuropathic pain associated with post-herpetic neuralgia.
ACCESSION #
48151533

 

Related Articles

  • Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia. Lancaster, Tim; McQuay, Henry // ACP Journal Club;Sep/Oct2002, Vol. 137 Issue 2, p52 

    Presents a systematic review of literature on effective treatments for reducing pain or disability in patients with postherpetic neuralgia (PHN). Comments on treatment choice for PHN; Study selection and data extraction; Analysis of the effectiveness of tricyclic antidepressants,...

  • "Detachment of the carinal hook following endobronchial intubation with a double lumen tube"  // BMC Anesthesiology;2011, Vol. 11 Issue 1, p20 

    The article focuses on the study of postherpetic neuralgia and its treatment with a capsaicin eight percent dermal patch NGX-4010 following pretreatment with lidocaine 2.5 percent and prilocaine 2.5 percent anesthetic cream. Patch application duration was used to assess tolerability and Numeric...

  • Intraoperative ventilation: incidence and risk factors for receiving large tidal volumes during general anesthesia.  // BMC Anesthesiology;2011, Vol. 11 Issue 1, p22 

    The article focuses on the study of postherpetic neuralgia and its treatment with a capsaicin eight percent dermal patch NGX-4010 following pretreatment with lidocaine 2.5 percent and prilocaine 2.5 percent anesthetic cream. Patch application duration was used to assess tolerability and Numeric...

  • A double blind randomized trial of wound infiltration with ropivacaine after breast cancer surgery with axillary nodes dissection.  // BMC Anesthesiology;2011, Vol. 11 Issue 1, p23 

    The article focuses on the study of postherpetic neuralgia and its treatment with a capsaicin eight percent dermal patch NGX-4010 following pretreatment with lidocaine 2.5 percent and prilocaine 2.5 percent anesthetic cream. Patch application duration was used to assess tolerability and Numeric...

  • A bibliometric search of citation classics in anesthesiology.  // BMC Anesthesiology;2011, Vol. 11 Issue 1, p24 

    The article focuses on the study of postherpetic neuralgia and its treatment with a capsaicin eight percent dermal patch NGX-4010 following pretreatment with lidocaine 2.5 percent and prilocaine 2.5 percent anesthetic cream. Patch application duration was used to assess tolerability and Numeric...

  • Tolerability of NGX-4010, a capsaicin 8% dermal patch, following pretreatment with lidocaine 2.5%/prilocaine 2.5% cream in patients with postherpetic neuralgia.  // BMC Anesthesiology;2011, Vol. 11 Issue 1, p25 

    The article focuses on the study of postherpetic neuralgia and its treatment with a capsaicin eight percent dermal patch NGX-4010 following pretreatment with lidocaine 2.5 percent and prilocaine 2.5 percent anesthetic cream. Patch application duration was used to assess tolerability and Numeric...

  • Managing Post-Herpetic Neuralgia. Shovlin, Joseph P. // Review of Optometry;12/15/2004, Vol. 141 Issue 12, p63 

    The article presents answers to queries on managing post-herpetic neuralgia. In reply to a question, Dr. H.S. Ghazi- Birry, 6D of the Southern College of Optometry in Memphis, Pennsylvania, says to start with 300mg of the anti-epileptic Neurontin once a day on day one, twice a day on day two and...

  • Treatments for postherpetic neuralgia. Chasuk, Robert // Journal of Family Practice;Sep1997, Vol. 45 Issue 3, p203 

    This article presents a study which examined the treatments for postherpetic neuralgia. The tricyclic antidepressants amitriptyline and desipramine are considered effective in relieving pain from established postherpetic neuralgia. Topical capsaicin has promise, but cannot be recommended...

  • NeurogesX Presents Positive Data From Trial Of Pain Patch. Shrine, Jim // BioWorld Today;6/8/2007, Vol. 18 Issue 111, p1 

    The article reports that positive data are being reported in Europe, where NeurogesX Inc. aims to seek its first approval, from a Phase III trial of pain patch in treating postherpetic neuralgia. The study of NGX-4010 demonstrated statistically essential pain relief versus a control path over...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics